Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children

NCT02747927 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

20099

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Placebo
BIOLOGICAL: Tetravalent Dengue Vaccine (TDV)

Sponsor

Takeda